Citations (83)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Virginia Ronco, Myriam Dilecce, Elena Lanati, Pier Luigi Canonico & Claudio Jommi. (2021) Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?. Journal of Pharmaceutical Policy and Practice 14:1.
Read now
Read now
Michał Pochopień, Tingting Qiu, Samuel Aballea, Emilie Clay & Mondher Toumi. (2021) Considering potential solutions for limitations and challenges in the health economic evaluation of gene therapies. Expert Review of Pharmacoeconomics & Outcomes Research 21:6, pages 1145-1158.
Read now
Read now
Tingting Qiu, Yitong Wang, Monique Dabbous, Eve Hanna, Ru Han, Shuyao Liang & Mondher Toumi. (2020) Current state of developing advanced therapies for rare diseases in the European Union. Expert Opinion on Orphan Drugs 8:10, pages 417-429.
Read now
Read now
Mariusz Chabowski, Beata Jankowska-Polańska, Katarzyna Lomper & Dariusz Janczak. (2018) The effect of coping strategy on quality of life in patients with NSCLC. Cancer Management and Research 10, pages 4085-4093.
Read now
Read now
Eve Hanna, Cécile Rémuzat, Pascal Auquier & Mondher Toumi. (2017) Gene therapies development: slow progress and promising prospect. Journal of Market Access & Health Policy 5:1.
Read now
Read now
Articles from other publishers (78)
Keqi Wang, Wei Xie & Sarah W. Harcum. (2023) Metabolic regulatory network kinetic modeling with multiple isotopic tracers for iPSCs. Biotechnology and Bioengineering.
Crossref
Crossref
Juan Carlos Rejon-Parrilla, Jaime Espin, Sarah Garner, Stanislav Kniazkov & David Epstein. (2023) Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries. Frontiers in Pharmacology 14.
Crossref
Crossref
Daniel Gladwell, Oriana Ciani, Adam Parnaby & Stephen Palmer. (2023) Surrogacy and the Valuation of ATMPs: Taking Our Place in the Evidence Generation/Assessment Continuum. PharmacoEconomics.
Crossref
Crossref
Niki Triantafyllou, Miriam Sarkis, Aikaterina Krassakopoulou, Nilay Shah, Maria M. Papathanasiou & Cleo Kontoravdi. (2023) Uncertainty quantification for gene delivery methods: A roadmap for pDNA manufacturing from phase I clinical trials to commercialization. Biotechnology Journal.
Crossref
Crossref
Michael Drummond, Oriana Ciani, Giulia Fornaro, Claudio Jommi, Eva Susanne Dietrich, Jaime Espin, Jean Mossman & Gerard de Pouvourville. (2023) How are health technology assessment bodies responding to the assessment challenges posed by cell and gene therapy?. BMC Health Services Research 23:1.
Crossref
Crossref
Georgina C. Wilkins, Katherine Lanyi, Alexander Inskip, Oladapo J. Ogunbayo, Petra Brhlikova & Dawn Craig. (2023) A pipeline analysis of advanced therapy medicinal products. Drug Discovery Today 28:5, pages 103549.
Crossref
Crossref
Kenny Man, Neil M. Eisenstein, David A. Hoey & Sophie C. Cox. (2023) Bioengineering extracellular vesicles: smart nanomaterials for bone regeneration. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Sherouk M. Tawfik, Aliaa A. Elhosseiny, Aya A. Galal, Martina B. William, Esraa Qansuwa, Rana M. Elbaz & Mohamed Salama. (2023) Health inequity in genomic personalized medicine in underrepresented populations: a look at the current evidence. Functional & Integrative Genomics 23:1.
Crossref
Crossref
Marziale Comito, Riccardo Monguzzi, Silvia Tagliapietra, Giovanni Palmisano & Giancarlo Cravotto. (2023) Towards Antibiotic Synthesis in Continuous-Flow Processes. Molecules 28:3, pages 1421.
Crossref
Crossref
Nikolaos Naziris & Costas Demetzos. 2023. Handbook of Computational Neurodegeneration. Handbook of Computational Neurodegeneration
629
653
.
Vasileios Karyotis, Cleopatra Bardaki & Panos Kourouthanassis. 2023. Handbook of Computational Neurodegeneration. Handbook of Computational Neurodegeneration
367
390
.
Vasileios Karyotis, Cleopatra Bardaki & Panos Kourouthanassis. 2020. Handbook of Computational Neurodegeneration. Handbook of Computational Neurodegeneration
1
25
.
Olga A. Krasilnikova, Denis S. Baranovskii, Anna O. Yakimova, Nadezhda Arguchinskaya, Anastas Kisel, Dmitry Sosin, Yana Sulina, Sergey A. Ivanov, Peter V. Shegay, Andrey D. Kaprin & Ilya D. Klabukov. (2022) Intraoperative Creation of Tissue-Engineered Grafts with Minimally Manipulated Cells: New Concept of Bone Tissue Engineering In Situ. Bioengineering 9:11, pages 704.
Crossref
Crossref
Martina Kropp, Nina Harmening, Thais Bascuas, Sandra Johnen, Eline De Clerck, Verónica Fernández, Mattia Ronchetti, Ruggero Cadossi, Cristina Zanini, Daniel Scherman, Zoltán Ivics, Corinne Marie, Zsuzsanna Izsvák & Gabriele Thumann. (2022) GMP-Grade Manufacturing and Quality Control of a Non-Virally Engineered Advanced Therapy Medicinal Product for Personalized Treatment of Age-Related Macular Degeneration. Biomedicines 10:11, pages 2777.
Crossref
Crossref
Camile Giaretta Sachetti, Augusto Barbosa Júnior, Antonio Carlos Campos de Carvalho, Antonia Angulo-Tuesta & Everton Nunes da Silva. (2022) Landscape of Brazilian research and development public funding in advanced therapies: lessons learned and a roadmap for middle-income economies. Cytotherapy 24:11, pages 1158-1165.
Crossref
Crossref
Sarah E Hughes, Christel McMullan, Anna Rowe, Ameeta Retzer, Rebecca Malpass, Camilla Bathurst, Elin Haf Davies, Chris Frost, Gary McNamara, Rosie Harding, Gary Price, Roger Wilson, Anita Walker, Philip N Newsome & Melanie Calvert. (2022) Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study. BMJ Open 12:9, pages e063199.
Crossref
Crossref
Will A.S. Hardy & Dyfrig A. Hughes. (2022) Methods for Extrapolating Survival Analyses for the Economic Evaluation of Advanced Therapy Medicinal Products. Human Gene Therapy 33:17-18, pages 845-856.
Crossref
Crossref
Andreea Avramescu, Richard Allmendinger, Manuel Lopez-Ibanez & Adriana G Lopes. (2022) Composite Facility Location Problems: A Case Study of Personalised Medicine. Composite Facility Location Problems: A Case Study of Personalised Medicine.
Shelly E. Tannenbaum & Benjamin E. Reubinoff. (2022)
Advances in
hPSC
expansion towards therapeutic entities: A review
. Cell Proliferation 55:8.
Crossref
Crossref
Souhaila H. El Moukhtari, Elisa Garbayo, Ana Fernández-Teijeiro, Carlos Rodríguez-Nogales, Patrick Couvreur & María J. Blanco-Prieto. (2022) Nanomedicines and cell-based therapies for embryonal tumors of the nervous system. Journal of Controlled Release 348, pages 553-571.
Crossref
Crossref
Paul Williams, Catherine Klersy, Chitra Karki, Dimitri Bennett, Ana María Rodríguez & Rachele Ciccocioppo. (2022) Mesenchymal Stem Cell Therapy Awareness, Knowledge, and Use for the Treatment of Fistulizing Crohn’s Disease: An International Survey Among Gastroenterologists and Colorectal Surgeons. Advances in Therapy 39:6, pages 2761-2777.
Crossref
Crossref
Nils A. Brechmann, Märta Jansson, Alice Hägg, Ryan Hicks, Johan Hyllner, Kristofer Eriksson & Véronique Chotteau. (2022) Proof-of-Concept of a Novel Cell Separation Technology Using Magnetic Agarose-Based Beads. Magnetochemistry 8:3, pages 34.
Crossref
Crossref
Sathish Muthu, Madhan Jeyaraman, Moinuddin Basha Kotner, Naveen Jeyaraman, Ramya Lakshmi Rajendran, Shilpa Sharma, Manish Khanna, Sree Naga Sowndary Rajendran, Ji Min Oh, Prakash Gangadaran & Byeong-Cheol Ahn. (2022) Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective. Bioengineering 9:3, pages 111.
Crossref
Crossref
Tingting Qiu, Michał Pochopień, Eve Hanna, Shuyao Liang, Yitong Wang, Ru Han, Mondher Toumi & Samuel Aballéa. (2022) Challenges in the market access of regenerative medicines, and implications for manufacturers and decision-makers: a systematic review. Regenerative Medicine 17:3, pages 119-139.
Crossref
Crossref
Renske M.T. ten Ham, Geert W.J. Frederix, Olivia Wu, Wim Goettsch, Hubert G.M. Leufkens, Olaf H. Klungel & Jarno Hoekman. (2022) Key Considerations in the Health Technology Assessment of Advanced Therapy Medicinal Products in Scotland, The Netherlands, and England. Value in Health 25:3, pages 390-399.
Crossref
Crossref
Lequina Myles & Terry David Church. (2022) An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies. Cytotherapy 24:3, pages 344-355.
Crossref
Crossref
Elisabete Gonçalves. (2021) Value-based pricing for advanced therapy medicinal products: emerging affordability solutions. The European Journal of Health Economics 23:2, pages 155-163.
Crossref
Crossref
Tingting Qiu, Michal Pochopien, Shuyao Liang, Gauri Saal, Ewelina Paterak, Justyna Janik & Mondher Toumi. (2022) Gene Therapy Evidence Generation and Economic Analysis: Pragmatic Considerations to Facilitate Fit-for-Purpose Health Technology Assessment. Frontiers in Public Health 10.
Crossref
Crossref
Silvia Pisani, Stefania Croce, Simone Mauramati, Marta Marmonti, Lorenzo Cobianchi, Irene Herman, Rossella Dorati, Maria Antonietta Avanzini, Ida Genta, Marco Benazzo & Bice Conti. (2022) Engineered Full Thickness Electrospun Scaffold for Esophageal Tissue Regeneration: From In Vitro to In Vivo Approach. Pharmaceutics 14:2, pages 252.
Crossref
Crossref
Ekin Begum Karahan & Guvenc Kockaya. (2022) Gene and Cell Therapies Overview Under the Light of Health Economics. Health Economics and Management Review 3:4, pages 15-22.
Crossref
Crossref
Astrid Holzinger & Hinrich Abken. (2022) Treatment with Living Drugs: Pharmaceutical Aspects of CAR T Cells. Pharmacology 107:9-10, pages 446-463.
Crossref
Crossref
Shahrbanoo Jahangir, Sareh Zeydabadinejad, Zhila Izadi, Mahdi Habibi-Anbouhi & Ensiyeh Hajizadeh-Saffar. 2022. Translational Autoimmunity. Translational Autoimmunity
319
359
.
Carolina Iglesias-Lopez, Antonia Agustí, Antoni Vallano & Merce Obach. (2021) Current landscape of clinical development and approval of advanced therapies. Molecular Therapy - Methods & Clinical Development 23, pages 606-618.
Crossref
Crossref
Marc-Phillip Mast, Harshvardhan Modh, Carole Champanhac, Jiong-Wei Wang, Gerrit Storm, Johannes Krämer, Volker Mailänder, Giorgia Pastorin & Matthias G. Wacker. (2021) Nanomedicine at the crossroads – A quick guide for IVIVC. Advanced Drug Delivery Reviews 179, pages 113829.
Crossref
Crossref
Carolina Iglesias-Lopez, Antònia Agustí, Antonio Vallano & Merce Obach. (2021) Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union. Frontiers in Pharmacology 12.
Crossref
Crossref
Tingting Qiu, Shuyao Liang, Yitong Wang, Claude Dussart, Borislav Borissov & Mondher Toumi. (2021) Reinforcing Collaboration and Harmonization to Unlock the Potentials of Advanced Therapy Medical Products: Future Efforts Are Awaited From Manufacturers and Decision-Makers. Frontiers in Public Health 9.
Crossref
Crossref
James B. Phillips. (2021) ‘EngNT’ — Engineering live neural tissue for nerve replacement. Emerging Topics in Life Sciences 5:5, pages 699-703.
Crossref
Crossref
Tyler L Jaynes. (2021) The legal ambiguity of advanced assistive bionic prosthetics: Where to define the limits of ‘enhanced persons’ in medical treatment. Clinical Ethics 16:3, pages 171-182.
Crossref
Crossref
Tingting Qiu, Yitong Wang, Shuyao Liang, Ru Han & Mondher Toumi. (2021) Partnership agreements for regenerative medicines: a database analysis and implications for future innovation. Regenerative Medicine 16:8, pages 733-755.
Crossref
Crossref
Nabil A. Alhakamy, David T. Curiel & Cory J. Berkland. (2021) The era of gene therapy: From preclinical development to clinical application. Drug Discovery Today 26:7, pages 1602-1619.
Crossref
Crossref
Kenny Man, Mathieu Y. Brunet, Maria Fernandez‐Rhodes, Soraya Williams, Liam M. Heaney, Lee A. Gethings, Angelica Federici, Owen G. Davies, David Hoey & Sophie C. Cox. (2021) Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast‐derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation. Journal of Extracellular Vesicles 10:9.
Crossref
Crossref
Arun Butreddy, Nagavendra Kommineni & Narendar Dudhipala. (2021) Exosomes as Naturally Occurring Vehicles for Delivery of Biopharmaceuticals: Insights from Drug Delivery to Clinical Perspectives. Nanomaterials 11:6, pages 1481.
Crossref
Crossref
Ilias Nikolits, Sabrina Nebel, Dominik Egger, Sebastian Kreß & Cornelia Kasper. (2021) Towards Physiologic Culture Approaches to Improve Standard Cultivation of Mesenchymal Stem Cells. Cells 10:4, pages 886.
Crossref
Crossref
Marina López-Paniagua, Ana de la Mata, Sara Galindo, Francisco Blázquez, Margarita Calonge & Teresa Nieto-Miguel. (2021) Advanced Therapy Medicinal Products for the Eye: Definitions and Regulatory Framework. Pharmaceutics 13:3, pages 347.
Crossref
Crossref
Muthu Parkkavi Sekar, Harshavardhan Budharaju, Allen Zennifer, Swaminathan Sethuraman, Niki Vermeulen, Dhakshinamoorthy Sundaramurthi & Deepak M Kalaskar. (2021) Current standards and ethical landscape of engineered tissues—3D bioprinting perspective. Journal of Tissue Engineering 12, pages 204173142110276.
Crossref
Crossref
Marta Carvalho, Bruno Sepodes & Ana Paula Martins. (2021) Patient access to gene therapy medicinal products: a comprehensive review. BMJ Innovations 7:1, pages 123-134.
Crossref
Crossref
Rachele Ciccocioppo, Patrizia Comoli, Giuseppe Astori, Francesca Bufalo, Malvina Prapa, Massimo Dominici & Franco Locatelli. (2020) Developing cell therapies as drug products. British Journal of Pharmacology 178:2, pages 262-279.
Crossref
Crossref
Antje Haas, Thomas Mayer, Anja Tebinka-Olbrich, Maximilian Blindzellner, Elisa Beggerow & Andreas Nickel. 2021. Arzneimittel-Kompass 2021. Arzneimittel-Kompass 2021
105
124
.
Nikolaos Naziris & Costas Demetzos. 2020. Handbook of Computational Neurodegeneration. Handbook of Computational Neurodegeneration
1
25
.
Sara Ravasio. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy
327
347
.
Ryosuke Kurauchi, Hiroi Kasai & Tatsuya Ito. (2020) Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Crossref
Doug Coyle, Isabelle Durand-Zaleski, Jasmine Farrington, Louis Garrison, Johann-Matthias Graf von der Schulenburg, Wolfgang Greiner, Louise Longworth, Aurélie Meunier, Anne-Sophie Moutié, Stephen Palmer, Zack Pemberton-Whiteley, Mark Ratcliffe, Jie Shen, Doug Sproule, Kun Zhao & Koonal Shah. (2020) HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies. The European Journal of Health Economics 21:9, pages 1421-1437.
Crossref
Crossref
Rick A Vreman, Thomas F Broekhoff, Hubert GM Leufkens, Aukje K Mantel-Teeuwisse & Wim G Goettsch. (2020) Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis. International Journal of Environmental Research and Public Health 17:22, pages 8309.
Crossref
Crossref
Kenny Man, Mathieu Y. Brunet, Marie-Christine Jones & Sophie C. Cox. (2020) Engineered Extracellular Vesicles: Tailored-Made Nanomaterials for Medical Applications. Nanomaterials 10:9, pages 1838.
Crossref
Crossref
Hosanna Brave & Ronan MacLoughlin. (2020) State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery. International Journal of Molecular Sciences 21:17, pages 6435.
Crossref
Crossref
Tingting Qiu, Eve Hanna, Monique Dabbous, Borisov Borislav & Mondher Toumi. (2020) Regenerative medicine regulatory policies: A systematic review and international comparison. Health Policy 124:7, pages 701-713.
Crossref
Crossref
Renske M.T. ten Ham, Anke M. Hövels, Olaf H. Klungel, Hubert G.M. Leufkens, Andre W. Broekmans & Jarno Hoekman. (2020) Development and Regulation of Gene and Cell-Based Therapies in Europe: A Quantification and Reflection. Trends in Pharmacological Sciences 41:2, pages 67-71.
Crossref
Crossref
Antonia Rotolo, Christian Chabannon & Roberto Gramignoli. (2020) Identification of hurdles in the development of cell-based therapies. Cytotherapy 22:2, pages 53-56.
Crossref
Crossref
Vaishali ShuklaEnrique Seoane-VazquezSouhiela FawazLawrence BrownRosa Rodriguez-Monguio. (2019) The Landscape of Cellular and Gene Therapy Products: Authorization, Discontinuations, and Cost. Human Gene Therapy Clinical Development 30:3, pages 102-113.
Crossref
Crossref
Yin Ren, Lukas D. Landegger & Konstantina M. Stankovic. (2019) Gene Therapy for Human Sensorineural Hearing Loss. Frontiers in Cellular Neuroscience 13.
Crossref
Crossref
V. A. Merkulov & E. V. Melnikova. (2019) Biomedical Cell Products or High-Tech Drugs?. BIOpreparations. Prevention, Diagnosis, Treatment 19:2, pages 94-98.
Crossref
Crossref
Annegret Vaggelas & Diane Seimetz. (2019) Expediting Drug Development: FDA’s New Regenerative Medicine Advanced Therapy Designation. Therapeutic Innovation & Regulatory Science 53:3, pages 364-373.
Crossref
Crossref
Steffen Zobel-Roos, Axel Schmidt, Fabian Mestmäcker, Mourad Mouellef, Maximilian Huter, Lukas Uhlenbrock, Martin Kornecki, Lara Lohmann, Reinhard Ditz & Jochen Strube. (2019) Accelerating Biologics Manufacturing by Modeling or: Is Approval under the QbD and PAT Approaches Demanded by Authorities Acceptable Without a Digital-Twin?. Processes 7:2, pages 94.
Crossref
Crossref
Lousineh Arakelian, Nobuo Kanai, Kulwinder Dua, Marlène Durand, Pierre Cattan & Takeshi Ohki. (2018) Esophageal tissue engineering: from bench to bedside. Annals of the New York Academy of Sciences 1434:1, pages 156-163.
Crossref
Crossref
Renske M.T. ten Ham, Jarno Hoekman, Anke M. Hövels, Andre W. Broekmans, Hubert G.M. Leufkens & Olaf H. Klungel. (2018) Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe. Molecular Therapy - Methods & Clinical Development 11, pages 121-130.
Crossref
Crossref
Sofieke de Wilde, Delphi G.M. Coppens, Jarno Hoekman, Marie L. de Bruin, Hubert G.M. Leufkens, Henk-Jan Guchelaar & Pauline Meij. (2018) EU decision-making for marketing authorization of advanced therapy medicinal products: a case study. Drug Discovery Today 23:7, pages 1328-1333.
Crossref
Crossref
Ralf Pörtner, Shreemanta K. Parida, Christiane Schaffer & Hans Hoffmeister. 2018. Stem Cells in Clinical Practice and Tissue Engineering. Stem Cells in Clinical Practice and Tissue Engineering.
E. Ferreira & R. M. Porter. (2018) Harnessing extracellular vesicles to direct endochondral repair of large bone defects. Bone & Joint Research 7:4, pages 263-273.
Crossref
Crossref
Mathew Baldwin, Sarah Snelling, Stephanie Dakin & Andrew Carr. (2018) Augmenting endogenous repair of soft tissues with nanofibre scaffolds. Journal of The Royal Society Interface 15:141, pages 20180019.
Crossref
Crossref
Zhiling Yu & Frances J. Richmond. 2018. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Helena Ferreira, Joana F. Fangueiro & Nuno M. Neves. 2018. Novel Biomaterials for Regenerative Medicine. Novel Biomaterials for Regenerative Medicine
127
146
.
N. A Aleksandrushkina, E. V Tarasova, P. I Makarevich, L. A Gabbasova, Zh. A Akopyan, A. A Kamalov & V. A Tkachuk. (2017) Legal regulation of biomedical cell products authorization and marketing in international practice. Genes & Cells 12:4, pages 97-108.
Crossref
Crossref
Marta Carvalho, Bruno Sepodes & Ana Paula Martins. (2017) Regulatory and Scientific Advancements in Gene Therapy: State-of-the-Art of Clinical Applications and of the Supporting European Regulatory Framework. Frontiers in Medicine 4.
Crossref
Crossref
S Simoens & I Huys. (2017) Market access of Spinraza (Nusinersen) for spinal muscular atrophy: intellectual property rights, pricing, value and coverage considerations. Gene Therapy 24:9, pages 539-541.
Crossref
Crossref
Milos Mihajlovic, Lambertus P. van den Heuvel, Joost G. Hoenderop, Jitske Jansen, Martijn J. Wilmer, Annemarie J. F. Westheim, Wil A. Allebes, Dimitrios Stamatialis, Luuk B. Hilbrands & Rosalinde Masereeuw. (2017) Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application. Scientific Reports 7:1.
Crossref
Crossref
Yusuf H Mirza & Sam Oussedik. (2017) Is there a role for stem cells in treating articular injury?. British Journal of Hospital Medicine 78:7, pages 372-377.
Crossref
Crossref
R. Steven Conlan, Simone Pisano, Marta I. Oliveira, Mauro Ferrari & Inês Mendes Pinto. (2017) Exosomes as Reconfigurable Therapeutic Systems. Trends in Molecular Medicine 23:7, pages 636-650.
Crossref
Crossref
Magdalini Papadaki. (2017) Adaptation through Collaboration: Developing Novel Platforms to Advance the Delivery of Advanced Therapies to Patients. Frontiers in Medicine 4.
Crossref
Crossref